昆药集团：目前公司经营情况正常，不存在应披露而未披露的重大事项

Group 1 - The company, Kunming Pharmaceutical Group, stated that its current operating conditions are normal and there are no significant undisclosed matters [1] - The company emphasizes its commitment to regulatory compliance and the protection of investors' rights [1] - The stock price fluctuations in the secondary market are influenced by multiple factors, including industry policies, and investors are advised to approach investments rationally [1]